Literature DB >> 8971094

Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes.

R Morishita1, S Nakamura, Y Nakamura, M Aoki, A Moriguchi, I Kida, Y Yo, K Matsumoto, T Nakamura, J Higaki, T Ogihara.   

Abstract

Endothelial cells are known to secrete various antiproliferative and vasodilating factors. Although injury of endothelial cells has been postulated as an initial trigger of the progression of atherosclerosis in patients with diabetes, the mechanisms of endothelial injury in diabetes are not yet clarified. Therefore, it is important to know the effects of high glucose on the factors that may influence endothelial cell growth. A novel member of endothelium-specific growth factors, hepatocyte growth factor (HGF), is produced in vascular cells. To investigate the effects of high glucose on vascular cells, we examined 1) the effects of high glucose on endothelial cell and vascular smooth muscle cell (VSMC) growth and 2) the effects of high glucose on local HGF production in endothelial cell and VSMC. Treatment of human aortic endothelial cell with a high concentration of D-glucose, but not mannitol and L-glucose, resulted in a significant decrease in cell number. Interestingly, addition of recombinant HGF attenuated high D-glucose-induced endothelial cell death. Therefore, we measured local HGF secretion of endothelial cell. Importantly, local HGF production was significantly decreased by high D-glucose treatment. In contrast, high D-glucose treatment resulted in a significant increase in the number of human aortic VSMCs, whereas local HGF production was significantly decreased in accordance with increase in D-glucose concentration. No significant changes in numbers were observed in VSMC treated with high mannitol and L-glucose. We also studied the mechanisms of local HGF suppression by high D-glucose. High D-glucose treatment stimulated transforming growth factor-beta (TGF-beta) concentration in endothelial cell and VSMC. Decreased local vascular HGF production was abolished by addition of anti-TGF-beta antibody. As TGF-beta inhibited local HGF production in endothelial cell and VSMC, increased TGF-beta induced by high D-glucose may suppress local HGF production. This study demonstrated that high D-glucose induced endothelial cell death, stimulated VSMC growth, and decreased local HGF production through the stimulation of TGF-beta production both in endothelial cell and VSMC. Overall, decrease in a local endothelial stimulant, HGF, by high D-glucose may be a trigger of endothelial injury in diabetes, potentially resulting in the progression of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8971094     DOI: 10.2337/diab.46.1.138

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

1.  Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy.

Authors:  A Cantón; R Burgos; C Hernández; C Mateo; R M Segura; J Mesa; R Simó
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

2.  Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease.

Authors:  S Mizuno; T Kurosawa; K Matsumoto; Y Mizuno-Horikawa; M Okamoto; T Nakamura
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

3.  Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus.

Authors:  K Shinoda; S Ishida; S Kawashima; T Wakabayashi; T Matsuzaki; M Takayama; K Shinmura; M Yamada
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

Review 4.  Diabetic cardiovascular disease: getting to the heart of the matter.

Authors:  Linda R Peterson; Clark R McKenzie; Jean E Schaffer
Journal:  J Cardiovasc Transl Res       Date:  2012-05-26       Impact factor: 4.132

5.  Production of hepatocyte growth factor during acute myocardial infarction.

Authors:  Y Zhu; Y Hojo; U Ikeda; K Shimada
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

Review 6.  Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus.

Authors:  Hiroyuki Konya; Masayuki Miuchi; Kahori Satani; Satoshi Matsutani; Taku Tsunoda; Yuzo Yano; Tomoyuki Katsuno; Tomoya Hamaguchi; Jun-Ichiro Miyagawa; Mitsuyoshi Namba
Journal:  World J Diabetes       Date:  2014-10-15

Review 7.  The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine.

Authors:  Toshikazu Nakamura; Shinya Mizuno
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

8.  Inducible HGF-secreting Human Umbilical Cord Blood-derived MSCs Produced via TALEN-mediated Genome Editing Promoted Angiogenesis.

Authors:  Hyun-Kyung Chang; Pyung-Hwan Kim; Hyun-Min Cho; Soo-Young Yum; Young-Jin Choi; YeonSung Son; DaBin Lee; InSung Kang; Kyung-Sun Kang; Goo Jang; Je-Yoel Cho
Journal:  Mol Ther       Date:  2016-06-10       Impact factor: 11.454

9.  Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach.

Authors:  Shengjun Fan; Qiang Geng; Zhenyu Pan; Xin Li; Lu Tie; Yan Pan; Xuejun Li
Journal:  BMC Syst Biol       Date:  2012-12-10

10.  Angiogenesis in the New Zealand obese mouse model fed with high fat diet.

Authors:  Adriana Balwierz; Anna Polus; Urszula Razny; Lukasz Wator; Grzegorz Dyduch; Romana Tomaszewska; Stephan Scherneck; Hans Joost; Aldona Dembinska-Kiec
Journal:  Lipids Health Dis       Date:  2009-04-06       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.